Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.

[1]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .

[2]  Hao Jiang,et al.  Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. , 2003, Molecular cancer therapeutics.

[3]  Sanjeev Banerjee,et al.  Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation , 2002, Oncogene.

[4]  J. Bright,et al.  Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes1 , 2002, The Journal of Immunology.

[5]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. , 2002, Carcinogenesis.

[6]  B. Aggarwal,et al.  Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.

[7]  K. Piwocka,et al.  Effect of Curcumin on the Apoptosis of Rodent and Human Nonproliferating and Proliferating Lymphoid Cells , 2000, Nutrition and cancer.

[8]  A. Katz,et al.  Therapeutic potential of curcumin in human prostate cancer—I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells , 2000, Prostate Cancer and Prostatic Diseases.

[9]  J. Russell,et al.  IL‐12 enhances IL‐2 function by inducing CD25 expression through a p38 mitogen‐activated protein kinase pathway , 2000, European journal of immunology.

[10]  N. H. Fischer,et al.  Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships. , 2000, Journal of natural products.

[11]  M. De la Fuente,et al.  Anti‐oxidants as modulators of immune function , 2000, Immunology and cell biology.

[12]  N. Sugihara,et al.  Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid. , 1999, Free radical biology & medicine.

[13]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[14]  S. Hwang,et al.  Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. , 1999, European journal of pharmacology.

[15]  D. Brenner,et al.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.

[16]  S. Hwang,et al.  Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin‐12 production in macrophages , 1999, British journal of pharmacology.

[17]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[18]  Y. Surh,et al.  Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. , 1999, Mutation research.

[19]  H. Ciolino,et al.  Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. , 1999, The Biochemical journal.

[20]  V. Steele,et al.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.

[21]  B. Chain,et al.  The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. , 1999, Free radical biology & medicine.

[22]  Huei-Wen Chen,et al.  Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells , 1998, British journal of pharmacology.

[23]  S. Gautam,et al.  Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). , 1998, Biochemical pharmacology.

[24]  R. Snapka,et al.  DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. , 1998, Journal of natural products.

[25]  M. Fontecave,et al.  Resveratrol, a remarkable inhibitor of ribonucleotide reductase , 1998, FEBS letters.

[26]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[27]  G A Colditz,et al.  Dietary fat intake and the risk of coronary heart disease in women. , 1997, The New England journal of medicine.

[28]  Y. Lou,et al.  Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[29]  S. Gautam,et al.  Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. , 1997, Hematopathology and molecular hematology.

[30]  P. Baeuerle,et al.  NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.

[31]  S. Kuo,et al.  Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.

[32]  K. Frenkel,et al.  Inhibitory effects of curcumin on tumorigenesis in mice , 1997, Journal of cellular biochemistry. Supplement.

[33]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[34]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[35]  C. Rao,et al.  Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.

[36]  Y. Lou,et al.  Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. , 1994, Cancer research.

[37]  W. Willett,et al.  Diet and health: what should we eat? , 1994, Science.

[38]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[39]  L. Wattenberg.  Inhibition of carcinogenesis by minor dietary constituents. , 1992, Cancer research.

[40]  S. Bhide,et al.  Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. , 1992, Nutrition and cancer.

[41]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[42]  F. Podlaski,et al.  Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). , 1991, Journal of immunology.

[43]  A. Conney,et al.  Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.

[44]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[45]  R. Smart,et al.  Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. , 1988, Cancer research.

[46]  L. Husmann,et al.  Cooperation between Helper T Cells and Cytotoxic T Lymphocyte Precursors , 1988, Annals of the New York Academy of Sciences.

[47]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[48]  S. Deodhar,et al.  Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). , 1980, The Indian journal of medical research.